HCC-话题@MedSci

#HCC#

114篇内容 | 4603人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1259570, encodeId=82f012595e0e3, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=European Radiology：肝功能成像评分在预测HCC切除术后肝功能衰竭方面的价值, objectType=article, longId=734133, objectId=c6d9e34133ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6d9e34133ee, replyNumber=0, likeNumber=81, createdTime=2022-08-03, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6d9e34133ee, moduleTitle=European Radiology：肝功能成像评分在预测HCC切除术后肝功能衰竭方面的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6d9e34133ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259569, encodeId=c5a712595696a, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=J AM COLL RADIOL：高风险患者对HCC筛查有何自己的“偏爱”？, objectType=article, longId=731500, objectId=0416e31500be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0416e31500be, replyNumber=0, likeNumber=92, createdTime=2022-07-08, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0416e31500be, moduleTitle=J AM COLL RADIOL：高风险患者对HCC筛查有何自己的“偏爱”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0416e31500be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259568, encodeId=24a312595685e, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=European Radiology:钇-90放射栓塞治疗在HCC 中的应用, objectType=article, longId=729012, objectId=cb6ce2901219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb6ce2901219, replyNumber=0, likeNumber=123, createdTime=2022-06-11, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb6ce2901219, moduleTitle=European Radiology:钇-90放射栓塞治疗在HCC 中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb6ce2901219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259567, encodeId=b6c8125956e60, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=BMC Cancer：BCLC B期肝细胞癌（HCC）患者初始使用仑伐替尼治疗的疗效, objectType=article, longId=726452, objectId=a4efe2645295, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4efe2645295, replyNumber=0, likeNumber=80, createdTime=2022-05-11, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4efe2645295, moduleTitle=BMC Cancer：BCLC B期肝细胞癌（HCC）患者初始使用仑伐替尼治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4efe2645295)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259566, encodeId=5f9f125956602, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=European Radiology：微波消融与射频消融在包膜下HCC中的应用, objectType=article, longId=726274, objectId=9a34e2627408, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a34e2627408, replyNumber=0, likeNumber=113, createdTime=2022-05-08, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a34e2627408, moduleTitle=European Radiology：微波消融与射频消融在包膜下HCC中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a34e2627408)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259565, encodeId=1eba12595658c, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=European Radiology：MRE在评估HCC微血管侵犯中的应用, objectType=article, longId=724333, objectId=af8be24333f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af8be24333f4, replyNumber=0, likeNumber=78, createdTime=2022-04-17, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af8be24333f4, moduleTitle=European Radiology：MRE在评估HCC微血管侵犯中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af8be24333f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259564, encodeId=b23c125956463, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=European Radiology：放射学列线图在cHCC-CC和ICC术前鉴别中的应用, objectType=article, longId=724247, objectId=fd2ae2424773, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd2ae2424773, replyNumber=0, likeNumber=74, createdTime=2022-04-15, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd2ae2424773, moduleTitle=European Radiology：放射学列线图在cHCC-CC和ICC术前鉴别中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd2ae2424773)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259563, encodeId=6e661259563eb, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=晚期肝癌（HCC）诊疗现状调研, objectType=article, longId=301841, objectId=af21301841f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af21301841f8, replyNumber=0, likeNumber=74, createdTime=2022-03-30, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af21301841f8, moduleTitle=晚期肝癌（HCC）诊疗现状调研, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af21301841f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259562, encodeId=e9db12595622b, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=European Radiology：Gd-EOB-DTPA增强MRI，实现HCC微血管浸润的无创评估！, objectType=article, longId=300420, objectId=9aee30042036, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9aee30042036, replyNumber=0, likeNumber=66, createdTime=2022-03-11, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9aee30042036, moduleTitle=European Radiology：Gd-EOB-DTPA增强MRI，实现HCC微血管浸润的无创评估！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9aee30042036)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259561, encodeId=606e1259561f4, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=Liver Cancer：TACTICS研究表明在TACE基础性加用索拉非尼可改善不可切除肝细胞癌（HCC）患者的PFS，但不能改善患者的OS, objectType=article, longId=299277, objectId=87e42992e798, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87e42992e798, replyNumber=0, likeNumber=76, createdTime=2022-02-22, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87e42992e798, moduleTitle=Liver Cancer：TACTICS研究表明在TACE基础性加用索拉非尼可改善不可切除肝细胞癌（HCC）患者的PFS，但不能改善患者的OS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87e42992e798)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259560, encodeId=d7371259560e9, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=Front Oncol：TACE联合AC（阿帕替尼+卡瑞利珠单抗）较AC治疗改善不可切除肝细胞癌（HCC）患者的预后, objectType=article, longId=295066, objectId=890729506606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=890729506606, replyNumber=0, likeNumber=84, createdTime=2022-02-04, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=890729506606, moduleTitle=Front Oncol：TACE联合AC（阿帕替尼+卡瑞利珠单抗）较AC治疗改善不可切除肝细胞癌（HCC）患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=890729506606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259559, encodeId=45d4125955949, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=Cancers：经动脉放射栓塞术(TARE)治疗不可切除肝细胞癌（HCC）安全有效, objectType=article, longId=294717, objectId=7d23294e17f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d23294e17f3, replyNumber=0, likeNumber=61, createdTime=2022-01-27, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d23294e17f3, moduleTitle=Cancers：经动脉放射栓塞术(TARE)治疗不可切除肝细胞癌（HCC）安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d23294e17f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259557, encodeId=0c56125955ee6, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=European Radiology：深卷积神经网络在预测HCC患者术前微血管浸润和临床预后方面的价值, objectType=article, longId=293038, objectId=658829303868, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=658829303868, replyNumber=0, likeNumber=84, createdTime=2021-12-30, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=658829303868, moduleTitle=European Radiology：深卷积神经网络在预测HCC患者术前微血管浸润和临床预后方面的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=658829303868)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259556, encodeId=888f1259556ce, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=Front Oncol：TACE联合仑伐替尼(TACE- L) vs TACE联合索拉非尼(TACE- S)治疗肝细胞癌(HCC)伴有门静脉癌栓(PVTT)患者的疗效和安全性, objectType=article, longId=292954, objectId=a2d3292954c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2d3292954c0, replyNumber=0, likeNumber=55, createdTime=2021-12-29, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2d3292954c0, moduleTitle=Front Oncol：TACE联合仑伐替尼(TACE- L) vs TACE联合索拉非尼(TACE- S)治疗肝细胞癌(HCC)伴有门静脉癌栓(PVTT)患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2d3292954c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259558, encodeId=d9e812595586d, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=Radiology：如果你还不不知道HCC MTM亚型，那一定要看过来！, objectType=article, longId=292482, objectId=204129248231, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=204129248231, replyNumber=0, likeNumber=54, createdTime=2021-12-23, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=204129248231, moduleTitle=Radiology：如果你还不不知道HCC MTM亚型，那一定要看过来！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=204129248231)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259555, encodeId=e5ed12595551b, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=Liver Cancer：Atezolizumab (ATEZO) + bevacizumab (BEVA)一线治疗晚期HCC进展后，二线治疗选择对比, objectType=article, longId=221201, objectId=587522120103, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=587522120103, replyNumber=0, likeNumber=54, createdTime=2021-11-30, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=587522120103, moduleTitle=Liver Cancer：Atezolizumab (ATEZO) + bevacizumab (BEVA)一线治疗晚期HCC进展后，二线治疗选择对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=587522120103)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259554, encodeId=4d151259554e4, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=GRAMD1A在HCC发展和治疗中的作用, objectType=article, longId=221029, objectId=c4d0221029a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4d0221029a7, replyNumber=0, likeNumber=65, createdTime=2021-11-27, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4d0221029a7, moduleTitle=GRAMD1A在HCC发展和治疗中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4d0221029a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259553, encodeId=d64e1259553f2, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=Radiology：在预测慢性乙型肝炎HCC的进展中，你知道这一评分系统吗？, objectType=article, longId=220827, objectId=3d7222082e46, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d7222082e46, replyNumber=0, likeNumber=80, createdTime=2021-11-24, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d7222082e46, moduleTitle=Radiology：在预测慢性乙型肝炎HCC的进展中，你知道这一评分系统吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d7222082e46)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259552, encodeId=94d712595522a, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=Front Oncol：Lenvatinib(仑伐替尼，LEN)联合免疫检查点抑制剂(ICIs)治疗晚期肝细胞癌（HCC）患者的安全性和有效性, objectType=article, longId=220495, objectId=dbd22204957c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbd22204957c, replyNumber=0, likeNumber=74, createdTime=2021-11-18, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbd22204957c, moduleTitle=Front Oncol：Lenvatinib(仑伐替尼，LEN)联合免疫检查点抑制剂(ICIs)治疗晚期肝细胞癌（HCC）患者的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbd22204957c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1259551, encodeId=418412595519a, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=Front Oncol：PD1抑制剂penpulimab联合安罗替尼一线治疗中国不可切除肝细胞癌（uHCC）患者的疗效和安全性, objectType=article, longId=220048, objectId=533b22004862, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=533b22004862, replyNumber=0, likeNumber=60, createdTime=2021-11-11, rootId=0, userName=jiyangfei, userId=8e4c53, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=533b22004862, moduleTitle=Front Oncol：PD1抑制剂penpulimab联合安罗替尼一线治疗中国不可切除肝细胞癌（uHCC）患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=533b22004862)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HCC

2020-05-29

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

European Radiology：肝功能成像评分在预测HCC切除术后肝功能衰竭方面的价值

2022-08-03

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

J AM COLL RADIOL：高风险患者对HCC筛查有何自己的“偏爱”？

2022-07-08

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

European Radiology:钇-90放射栓塞治疗在HCC 中的应用

2022-06-11

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

BMC Cancer：BCLC B期肝细胞癌（HCC）患者初始使用仑伐替尼治疗的疗效

2022-05-11

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

European Radiology：微波消融与射频消融在包膜下HCC中的应用

2022-05-08

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

European Radiology：MRE在评估HCC微血管侵犯中的应用

2022-04-17

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

European Radiology：放射学列线图在cHCC-CC和ICC术前鉴别中的应用

2022-04-15

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

晚期肝癌（HCC）诊疗现状调研

2022-03-30

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

European Radiology：Gd-EOB-DTPA增强MRI，实现HCC微血管浸润的无创评估！

2022-03-11

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

Liver Cancer：TACTICS研究表明在TACE基础性加用索拉非尼可改善不可切除肝细胞癌（HCC）患者的PFS，但不能改善患者的OS

2022-02-22

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

Front Oncol：TACE联合AC（阿帕替尼+卡瑞利珠单抗）较AC治疗改善不可切除肝细胞癌（HCC）患者的预后

2022-02-04

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

Cancers：经动脉放射栓塞术(TARE)治疗不可切除肝细胞癌（HCC）安全有效

2022-01-27

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

European Radiology：深卷积神经网络在预测HCC患者术前微血管浸润和临床预后方面的价值

2021-12-30

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

Front Oncol：TACE联合仑伐替尼(TACE- L) vs TACE联合索拉非尼(TACE- S)治疗肝细胞癌(HCC)伴有门静脉癌栓(PVTT)患者的疗效和安全性

2021-12-29

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

Radiology：如果你还不不知道HCC MTM亚型，那一定要看过来！

2021-12-23

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

Liver Cancer：Atezolizumab (ATEZO) + bevacizumab (BEVA)一线治疗晚期HCC进展后，二线治疗选择对比

2021-11-30

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

GRAMD1A在HCC发展和治疗中的作用

2021-11-27

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

Radiology：在预测慢性乙型肝炎HCC的进展中，你知道这一评分系统吗？

2021-11-24

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

Front Oncol：Lenvatinib(仑伐替尼，LEN)联合免疫检查点抑制剂(ICIs)治疗晚期肝细胞癌（HCC）患者的安全性和有效性

2021-11-18

jiyangfei (审核中...)

前往app查看评论内容

#HCC#

Front Oncol：PD1抑制剂penpulimab联合安罗替尼一线治疗中国不可切除肝细胞癌（uHCC）患者的疗效和安全性

2021-11-11

科室
- - 订阅+
  - 更多科室
工具
服务